
    
      The study period per patient is 16-20 weeks maximum and is conducted as follows :

        -  Run-in period: 2 weeks or 6 weeks for patients under fibrate treatment at screening (4
           weeks fibrate wash-out + 2 weeks placebo run-in);

        -  Treatment period: 12 weeks;

        -  Follow-up period: 2 weeks.
    
  